1. Home
  2. TNXP vs ALCO Comparison

TNXP vs ALCO Comparison

Compare TNXP & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • ALCO
  • Stock Information
  • Founded
  • TNXP 2007
  • ALCO 1960
  • Country
  • TNXP United States
  • ALCO United States
  • Employees
  • TNXP N/A
  • ALCO N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • ALCO
  • Sector
  • TNXP Health Care
  • ALCO
  • Exchange
  • TNXP Nasdaq
  • ALCO Nasdaq
  • Market Cap
  • TNXP 207.5M
  • ALCO 224.5M
  • IPO Year
  • TNXP N/A
  • ALCO N/A
  • Fundamental
  • Price
  • TNXP $39.78
  • ALCO $32.25
  • Analyst Decision
  • TNXP Strong Buy
  • ALCO
  • Analyst Count
  • TNXP 2
  • ALCO 0
  • Target Price
  • TNXP $585.00
  • ALCO N/A
  • AVG Volume (30 Days)
  • TNXP 1.3M
  • ALCO 31.5K
  • Earning Date
  • TNXP 05-12-2025
  • ALCO 05-13-2025
  • Dividend Yield
  • TNXP N/A
  • ALCO 0.62%
  • EPS Growth
  • TNXP N/A
  • ALCO N/A
  • EPS
  • TNXP N/A
  • ALCO N/A
  • Revenue
  • TNXP $10,041,000.00
  • ALCO $49,419,000.00
  • Revenue This Year
  • TNXP $12.17
  • ALCO $22.90
  • Revenue Next Year
  • TNXP $789.15
  • ALCO N/A
  • P/E Ratio
  • TNXP N/A
  • ALCO N/A
  • Revenue Growth
  • TNXP N/A
  • ALCO 23.36
  • 52 Week Low
  • TNXP $6.76
  • ALCO $24.20
  • 52 Week High
  • TNXP $558.08
  • ALCO $34.08
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 74.56
  • ALCO 71.51
  • Support Level
  • TNXP $25.40
  • ALCO $31.55
  • Resistance Level
  • TNXP $37.84
  • ALCO $31.82
  • Average True Range (ATR)
  • TNXP 4.17
  • ALCO 0.79
  • MACD
  • TNXP 1.75
  • ALCO 0.18
  • Stochastic Oscillator
  • TNXP 87.00
  • ALCO 94.97

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

Share on Social Networks: